243 related articles for article (PubMed ID: 32638023)
1. Elevated Blood Mitochondrial DNA in Early Life Among Uninfected Children Exposed to Human Immunodeficiency Virus and Combination Antiretroviral Therapy in utero.
Ajaykumar A; Zhu M; Kakkar F; Brophy J; Bitnun A; Alimenti A; Soudeyns H; Saberi S; Albert AYK; Money DM; Côté HCF;
J Infect Dis; 2021 Feb; 223(4):621-631. PubMed ID: 32638023
[TBL] [Abstract][Full Text] [Related]
2. Growth differences by school-age and adolescence according to in utero and peripartum antiretroviral therapy exposure among Ugandan children.
Awadu JE; Zalwango SK; Sikorskii A; Giordani B; Bovin MJ; Musoke PM; Ezeamama AE
Medicine (Baltimore); 2023 Jan; 102(4):e32677. PubMed ID: 36705393
[TBL] [Abstract][Full Text] [Related]
3. Antiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women.
Aldrovandi GM; Chu C; Shearer WT; Li D; Walter J; Thompson B; McIntosh K; Foca M; Meyer WA; Ha BF; Rich KC; Moye J
Pediatrics; 2009 Dec; 124(6):e1189-97. PubMed ID: 19933732
[TBL] [Abstract][Full Text] [Related]
4. Neurological development of children who are HIV-exposed and uninfected.
Toledo G; Côté HCF; Adler C; Thorne C; Goetghebuer T
Dev Med Child Neurol; 2021 Oct; 63(10):1161-1170. PubMed ID: 33987826
[TBL] [Abstract][Full Text] [Related]
5. Perinatal exposure to antiretroviral therapy is associated with increased blood mitochondrial DNA levels and decreased mitochondrial gene expression in infants.
Côté HC; Raboud J; Bitnun A; Alimenti A; Money DM; Maan E; Costei A; Gadawski I; Diong C; Read S; Shen S; Harrigan PR; Burdge DR; King SM; Forbes JC
J Infect Dis; 2008 Sep; 198(6):851-9. PubMed ID: 18684095
[TBL] [Abstract][Full Text] [Related]
6. Safety of in-utero antiretroviral exposure: neurologic outcomes in children who are HIV-exposed but uninfected.
Crowell CS; Williams PL; Yildirim C; Van Dyke RB; Smith R; Chadwick EG; Seage GR; Diperna A; Hazra R;
AIDS; 2020 Jul; 34(9):1377-1387. PubMed ID: 32310900
[TBL] [Abstract][Full Text] [Related]
7. Neurodevelopment of children who are HIV-exposed and uninfected in Kenya.
Bulterys MA; Njuguna I; King'e M; Chebet D; Moraa H; Gomez L; Onyango A; Malavi K; Nzia G; Chege M; Neary J; Wagner AD; Lawley KA; Wamalwa D; Benki-Nugent S; John-Stewart G
J Int AIDS Soc; 2023 Oct; 26 Suppl 4(Suppl 4):e26149. PubMed ID: 37909174
[TBL] [Abstract][Full Text] [Related]
8. In utero/peripartum antiretroviral therapy exposure and mental health outcomes at 8-18 years old: A longitudinal comparative study of children with perinatally acquired HIV, children perinatally HIV exposed but uninfected, and children unexposed uninfected from Uganda.
Coventry A; Sikorskii A; Zalwango SK; Familiar-Lopez I; Cardino VN; Giordani B; Ezeamama AE
Res Nurs Health; 2024 Apr; 47(2):195-207. PubMed ID: 38031814
[TBL] [Abstract][Full Text] [Related]
9. Placental Mitochondrial Toxicity, Oxidative Stress, Apoptosis, and Adverse Perinatal Outcomes in HIV Pregnancies Under Antiretroviral Treatment Containing Zidovudine.
Hernández S; Catalán-García M; Morén C; García-Otero L; López M; Guitart-Mampel M; Milisenda J; Coll O; Cardellach F; Gratacós E; Miró Ò; Garrabou G
J Acquir Immune Defic Syndr; 2017 Aug; 75(4):e113-e119. PubMed ID: 28234688
[TBL] [Abstract][Full Text] [Related]
10. Leukocyte Telomere Length at Birth and During the Early Life of Children Exposed to but Uninfected With HIV After In Utero Exposure to Antiretrovirals.
Ajaykumar A; Soudeyns H; Kakkar F; Brophy J; Bitnun A; Alimenti A; Albert AYK; Money DM; Côté HCF; ;
J Infect Dis; 2018 Feb; 217(5):710-720. PubMed ID: 29228317
[TBL] [Abstract][Full Text] [Related]
11. Perinatal outcomes, mitochondrial toxicity and apoptosis in HIV-treated pregnant women and in-utero-exposed newborn.
Hernàndez S; Morén C; López M; Coll O; Cardellach F; Gratacós E; Miró O; Garrabou G
AIDS; 2012 Feb; 26(4):419-28. PubMed ID: 22156962
[TBL] [Abstract][Full Text] [Related]
12. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.
Culnane M; Fowler M; Lee SS; McSherry G; Brady M; O'Donnell K; Mofenson L; Gortmaker SL; Shapiro DE; Scott G; Jimenez E; Moore EC; Diaz C; Flynn PM; Cunningham B; Oleske J
JAMA; 1999 Jan; 281(2):151-7. PubMed ID: 9917118
[TBL] [Abstract][Full Text] [Related]
13. Higher Hospitalization Rates in Children Born HIV-exposed Uninfected in British Columbia, Canada, Between 1990 and 2012.
Li SNJ; Albert A; Piske M; Janssen PA; Alimenti A; Jesson J; Côté HCF; Sauvé L
Pediatr Infect Dis J; 2022 Feb; 41(2):124-130. PubMed ID: 34711783
[TBL] [Abstract][Full Text] [Related]
14. Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants.
Williams PL; Marino M; Malee K; Brogly S; Hughes MD; Mofenson LM;
Pediatrics; 2010 Feb; 125(2):e250-60. PubMed ID: 20083530
[TBL] [Abstract][Full Text] [Related]
15. Blood mitochondrial DNA mutations in HIV-infected women and their infants exposed to HAART during pregnancy.
Jitratkosol MH; Sattha B; Maan EJ; Gadawski I; Harrigan PR; Forbes JC; Alimenti A; van Schalkwyk J; Money DM; Côté HC;
AIDS; 2012 Mar; 26(6):675-83. PubMed ID: 22436539
[TBL] [Abstract][Full Text] [Related]
16. Evidence of Subclinical mtDNA Alterations in HIV-Infected Pregnant Women Receiving Combination Antiretroviral Therapy Compared to HIV-Negative Pregnant Women.
Money DM; Wagner EC; Maan EJ; Chaworth-Musters T; Gadawski I; van Schalkwyk JE; Forbes JC; Burdge DR; Albert AY; Lohn Z; Côté HC;
PLoS One; 2015; 10(8):e0135041. PubMed ID: 26247211
[TBL] [Abstract][Full Text] [Related]
17. Lower Neurocognitive Functioning in HIV-Exposed Uninfected Children Compared With That in HIV-Unexposed Children.
Benki-Nugent SF; Yunusa R; Mueni A; Laboso T; Tamasha N; Njuguna I; Gómez L; Wamalwa DC; Tapia K; Maleche-Obimbo E; Bangirana P; Boivin MJ; John-Stewart GC
J Acquir Immune Defic Syndr; 2022 Apr; 89(4):441-447. PubMed ID: 35202050
[TBL] [Abstract][Full Text] [Related]
18. Developmental Disorder Probability Scores at 6-18 Years Old in Relation to In-Utero/Peripartum Antiretroviral Drug Exposure among Ugandan Children.
Awadu JE; Sikorskii A; Zalwango S; Coventry A; Giordani B; Ezeamama AE
Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35329408
[TBL] [Abstract][Full Text] [Related]
19. Early child development in children who are HIV-exposed uninfected compared to children who are HIV-unexposed: observational sub-study of a cluster-randomized trial in rural Zimbabwe.
Ntozini R; Chandna J; Evans C; Chasekwa B; Majo FD; Kandawasvika G; Tavengwa NV; Mutasa B; Mutasa K; Moulton LH; Humphrey JH; Gladstone MJ; Prendergast AJ;
J Int AIDS Soc; 2020 May; 23(5):e25456. PubMed ID: 32386127
[TBL] [Abstract][Full Text] [Related]
20. Point-of-care capillary blood lactate measurements in human immunodeficiency virus-uninfected children with in utero exposure to human immunodeficiency virus and antiretroviral medications.
Crain MJ; Williams PL; Griner R; Tassiopoulos K; Read JS; Mofenson LM; Rich KC;
Pediatr Infect Dis J; 2011 Dec; 30(12):1069-74. PubMed ID: 22051859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
